DocGo Inc. (DCGO) AI Stock Analysis

DocGo, Inc. is a provider of mobile health and medical transportation services, catering to healthcare providers across the United States and the United Kingdom. Established in 2015 and based in New York, New York, the company delivers emergency response services as well as non-emergency ambulance and wheelchair transportation. In addition, DocGo operates a mobile platform facilitating medical visits at home or in office settings. The company also supports public health initiatives through COVID-19 testing services and offers event services that deliver on-site healthcare support at major gatherings, including sporting events and concerts.

DocGo grew annual revenue from $318.7M in FY2021 to a peak of $624.3M in FY2023, before revenue fell 1.2% in FY2024 to $616.6M and dropped 47.7% in FY2025 to $322.2M. Gross margin shifted from 34.4% in FY2021 to 30.7% in FY2025. Operating margin declined from 4.8% in FY2021 to -27.7% in FY2025, resulting in a net loss of -$182.4M compared to net income of $20.0M in FY2024. For the trailing twelve months ended June 30, 2026, revenue was $294.7M with an operating margin of -24.4%. In the latest quarter, quarterly revenue fell 8.7% year-over-year while quarterly earnings grew 9.0%.

As of June 30, 2026, DocGo held $25.2M in cash and short-term investments against total debt of $25.9M, leaving net debt at $672,807. The company maintains a current ratio of 1.66 and a debt-to-equity ratio of 0.22, with shareholders' equity of $119.1M and total assets of $186.8M. Operating cash flow in FY2025 reached $34.5M, supporting free cash flow of $27.0M. During FY2025, capital expenditures were $7.4M, while share buybacks totaled $10.8M, contributing to a 5-year share count change of -1.4%.

DocGo trades at a forward P/E of 60.2x, above the 17.3x median of its US-listed Healthcare peers. Its enterprise value to EBITDA ratio stands at 5.6x, compared to the peer median of 12.0x, while its price-to-sales multiple is 0.1x against the peer median of 4.1x. The company carries a market capitalization of $26.9M and an enterprise value of $36.5M. Over the past year, the stock fell 77.7%, trailing the S&P 500 return of 16.8%, and its 5-year return of -97.3% lagged the index return of 83.0%.

Wall Street coverage includes 1 Strong Buy, 1 Buy, and 3 Hold ratings. The mean price target is $1.88, representing a 589.4% premium over the last close of $0.27. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $306.5M and an EPS of -$0.79. For the next fiscal year, 2 analysts project revenue of $325.8M and positive EPS of $0.14. DocGo beat EPS estimates in 2 of the last 4 quarters, and its next earnings date is November 9, 2026.

This page is an AI-written research summary of DocGo Inc. (DCGO). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: DCGO income statement, DCGO balance sheet, DCGO key metrics, DCGO analyst forecast, DCGO chart. See the DCGO stock overview for the latest quote and news.